Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Haoxi Health Technology Limited Class A ( (HAO) ) just unveiled an update.
On December 8, 2025, Haoxi Health Technology Limited held an extraordinary general meeting where shareholders approved several significant changes. These included increasing the voting rights of Class B shares from ten to thirty votes, expanding the authorized share capital, and consolidating shares at a ratio determined by the board. These changes aim to enhance the company’s governance structure and financial flexibility, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited operates in the health technology industry, focusing on providing innovative health solutions. The company is based in Beijing, China, and is involved in the development and distribution of health-related technologies and services.
Average Trading Volume: 470,563
Technical Sentiment Signal: Sell
Current Market Cap: $2.93M
For detailed information about HAO stock, go to TipRanks’ Stock Analysis page.